ALX Oncology Holdings Inc. (ALXO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 60.63M |
| Enterprise Value | 49.48M |
| P/E Ratio | -1.81 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.5 |
| Return On Equity | -0.9 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -99.39M |
| Net Income | -101.7M |
| Diluted EPS | -1.9 |
| Total Cash | 138.23M |
| Total Cash/Share | 1.02 |
| Total Debt | 9.71M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 9.71 |
| Book Value Per Share | 1 |
| 52-Week Change | 85.45 |
| 52-Week High | 2.66 |
| 52-Week Low | 0.96 |
| Moving Average 50 Days | 1.95 |
| Moving Average 200 Days | 1.79 |
| Average Volume | 1.42M |
| Shares Outstanding | 134.56M |
| % Held by Institutions | 173.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |